drugset / Trial / NCT00572819

Hysteroscopy After Pretreatment With Misoprostol and Estradiol Trial

NCT00572819

Phase 3 Completed 100 enrolled Ullevaal University Hospital Helse Nord · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to investigate whether 1000 micrograms of self-administered vaginal misoprostol 12 hours before operative hysteroscopy results in effective preoperative cervical ripening after two weeks pretreatment with 25 micrograms daily vaginal estradiol, compared to placebo (lactosum monohydricum) in postmenopausal women.

Timeline

Start
2008-01
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 1000 ug Intravenous

Indications